New FDA Drug Approved for Endometriosis Pain

November 01, 2022

20170830_Dr. Latasha Murphy OBGYN Headshot_Redos-1.jpg

There is a new tool to treat endometriosis, a painful disorder in which tissue that normally lines the inside of the uterus grows outside it, and is difficult to treat.

A drug called Myfembree is now approved by the Food and Drug Administration for treatment of moderate to severe endometriosis pain.

According to Latasha N. Murphy, M.D., FACOG, a skilled board certified gynecologist and surgeon in The Gynecology Center at Mercy, the drug isn't new. Until now, it has been used to treat patients who are pre-menopausal with uterine fibroids, and she has seen great improvement in those patients.

Now, it's approved for endometriosis. As with any drug, there are possible side effects.

"The most common side effects would be anything that comes from dropping estrogen levels. That would be hot flashes, night sweats, sometimes a decreased mood, so depression is a possibility," Dr. Murphy said.

Myfembree comes in the form of a pill, taken once daily.

View Mercy gynecologist Dr. Latasha Murphy's interview regarding Myfembree for treating endometriosis pain.

About Mercy

Founded in 1874 in Downtown Baltimore by the Sisters of Mercy, Mercy Medical Center is a 183-licensed bed, acute care, university-affiliated teaching hospital. Mercy has been recognized as a high-performing Maryland hospital (U.S. News & World Report); has achieved an overall 5-Star quality, safety, and patient experience rating (Centers for Medicare and Medicaid Services); is A-rated for Hospital Safety (Leapfrog Hospital Safety Grade); and is certified by the American Nurses Credentialing Center as a Magnet™ hospital. Mercy Health Services is a not-for-profit health system and the parent company of Mercy Medical Center and Mercy Personal Physicians.

Media Contact 
Dan Collins, Senior Director of Media Relations
Office: 410-332-9714
Cell: 410-375-7342
Email: dcollins@mdmercy.com

BuntingAtSunset---DSC_0765.jpg